Literature DB >> 23684670

A novel homozygous mutation of GJC2 derived from maternal uniparental disomy in a female patient with Pelizaeus-Merzbacher-like disease.

Keiko Shimojima1, Ryuta Tanaka, Shino Shimada, Noriko Sangu, Junko Nakayama, Nobuaki Iwasaki, Toshiyuki Yamamoto.   

Abstract

Pelizaeus-Merzbacher-like disease (PMLD) is an autosomal recessive hypomyelinating disorder of the central nervous system characterized by nystagmus, motor developmental delay, ataxia, and progressive spasticity. The gap junction protein gamma-2 gene (GJC2), encoding the gap junction protein connexin 47, is one of the genes responsible for this condition. In this study, a novel homozygous mutation in GJC2 (c.746C>G; p.P249R) was identified in a 21-year-old female patient with PMLD. Although her mother was a carrier of this mutation, the Mendelian inheritance pattern could not be determined because the paternal sample was unavailable. Alternatively, chromosomal microarray testing together with single nucleotide polymorphism typing (CGH+SNP) was performed to determine the gene copy number and analyze the haplotype in the 1q42.13 region in which GJC2 is located. The result showed no deletion, but the GJC2 region was involved in the loss-of-heterozygosity region. Furthermore, haplotype of chromosome 1, in which GJC2 is located, revealed that both copies of chromosome 1 were derived from the patient's mother, indicating maternal uniparental disomy of chromosome 1. This study showed the advantage of the SNP genotyping microarray for detecting the origin of the mutation. Crown
Copyright © 2013. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23684670     DOI: 10.1016/j.jns.2013.04.017

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Elucidation of the pathogenic mechanism and potential treatment strategy for a female patient with spastic paraplegia derived from a single-nucleotide deletion in PLP1.

Authors:  Keiko Yamamoto-Shimojima; Taichi Imaizumi; Yusuke Aoki; Ken Inoue; Tadashi Kaname; Yusuke Okuno; Hideki Muramatsu; Kohji Kato; Toshiyuki Yamamoto
Journal:  J Hum Genet       Date:  2019-04-19       Impact factor: 3.172

2.  Application of multiplex ligation-dependent probe amplification, and identification of a heterozygous Alu-associated deletion and a uniparental disomy of chromosome 1 in two patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

Authors:  Yuka Aoyama; Toshiyuki Yamamoto; Naomi Sakaguchi; Mika Ishige; Toju Tanaka; Tomoko Ichihara; Katsuaki Ohara; Hiroko Kouzan; Yasutomi Kinosada; Toshiyuki Fukao
Journal:  Int J Mol Med       Date:  2015-04-14       Impact factor: 4.101

3.  Mosaic partial pericentromeric trisomy 8 and maternal uniparental disomy in a male patient with autism spectrum disorder.

Authors:  Dina F Ahram; Danae Stambouli; Aleksandra Syrogianni; Yasser Al-Sarraj; Spyridon Gerou; Hatem El-Shanti; Marios Kambouris
Journal:  Clin Case Rep       Date:  2016-10-21

4.  Complete uniparental disomy of chromosome 1 in a child with isolated developmental delay.

Authors:  Violet Wallerstein; Leon Grant; Robert Wallerstein
Journal:  Clin Case Rep       Date:  2022-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.